日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

chinadaily.com.cn
left corner left corner
China Daily Website

Medical reforms spell out profit for pharma giants

Updated: 2013-04-13 14:37
By Liu Jie ( China Daily)

China now has 148 million people with pre-diabetes on top of an existing 92.4 million diabetes patients.

The number of patients is forecast to reach 130 million by 2030, creating medical costs related to type-2 diabetes of $47.2 billion, according to International Diabetes Federation.

In the China National Plan for Chronic Diseases Prevention and Treatment (2012-2015), diabetes has been given specific importance.

"Our advantage is in early-stage diabetes treatment. Our Glucophage (an oral diabetes medicine that helps control blood sugar levels) is recommended as initial treatment within national guidelines," said Jean-Christophe Pointeau, president of Bristol-Myers China.

The medicine is on China's essential drug list and Pointeau said he expects another Bristol-Myers product - Onglyza, a prescription type 2 diabetes medicine - also to be included.

Another major international name, Boston Scientific Co, has just announced clinical results of a trial evaluating the safety and effectiveness of a cardiovascular stent system in China.

Clinical trials are the prerequisite of new product introduction.

The US company is also working to introduce more specialist treatment to the Chinese market, including those involved in cardiology and endoscopy, especially in the treatment of chronic conditions, said Michael F. Mahoney, Boston Scientific's CEO.

Since entering China in 1997, the company's average annual growth by sales has kept at 30 percent and it expects to exceed that figure in coming years.

The company is also building a research and development, training and head office complex in Shanghai, which is expected to be completed in September.

China expects to increase its medical spending by 27 percent this year, and to more than double the number of drugs in its national reimbursement medicine list from 205 to 520.

China's medical insurance will cover an additional 20 serious illnesses, including lung and gastric cancers, chronic myelocytic leukemia, hemophilia, type-1 diabetes and cerebral infarction.

These are also other serious diseases seeing increased occurrence in China, which lack high-quality diagnosis and treatment equipment being produced by domestic companies, according to a recent report from Bank of China International (China) Ltd.

Sanofi's Lam added that so far the company cannot assess how successful its investment in the Chinese market has been, "but we believe in the long run, it will be absolutely positive to us".

Sanofi's diabetes business increased 25 percent year-on-year in 2012, compared with the average growth of the sector at 15 percent.

 
 
...
主站蜘蛛池模板: 日本精品久久 | 亚洲美女在线播放 | 一区二区在线免费观看视频 | 在线观看毛片视频 | 日韩深夜福利 | 91亚洲精品在线 | 可以在线观看的av | 中文字幕在线观看你懂的 | 91在线免费视频观看 | 国产三级av在线 | 午夜爱| 国产一区二区三区在线看 | 五月婷婷视频在线 | 福利资源在线 | www.欧美com | 五月天婷婷综合网 | 亚洲网在线观看 | 天堂中文在线网 | 成人午夜网 | 男女公园野战活春 | 精品欧美久久 | 91美女福利视频 | 好吊妞精品视频 | 国产在线观看你懂的 | 日本一区二区久久 | 青娱乐成人 | 淫片在线观看 | 国产综合91 | 农村老妇性真猛 | 午夜在线播放 | 麻豆视频免费在线 | 久久国产麻豆 | 影音先锋毛片 | 午夜黄色在线观看 | 免费看一级片 | 欧美精品中文 | 黄色一级片免费 | 男人的天堂成人 | 香蕉伊人网 | 香蕉精品视频在线观看 | 日韩午夜网站 |